Cracking the Code: Nucleic Acid Medicines Coming of Age

The 2025 conference brings together leading academics and industry professionals to explore developments and challenges in the rapidly evolving field of nucleic acid medicines.
Cracking the Code: Nucleic Acid Medicines Coming of Age
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Organized by Alnylam, Ionis, HSCI, Nature, Nature Biotechnology and Nature Reviews Drug Discovery.

The 2025 conference brings together leading academics and industry professionals to explore developments and challenges in the rapidly evolving field of nucleic acid medicines. By uniting researchers from basic science, translational medicine, promising start-ups and biotechnology companies, the event aims to create a unique environment for meaningful dialogue and collaboration. 

The conference will feature in-depth discussions on: 

  • Translational developments of basic nucleic acid biology 
  • Recent clinical successes using nucleic acid gene therapies 
  • Advancements in nucleic acid chemistry 

The three-day program offers comprehensive coverage of applications of fundamental biology, a panel discussion and ample space to connect with editors, speakers and fellow attendees. 

Register, submit an abstract or learn more here

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Gene Therapy
Life Sciences > Health Sciences > Clinical Medicine > Therapeutics > Gene Therapy
Nucleic Acid Therapeutics
Life Sciences > Biological Sciences > Biotechnology > Biologics > Nucleic Acid Therapeutics
Genetics and Genomics
Life Sciences > Biological Sciences > Genetics and Genomics
RNA Vaccines
Life Sciences > Biological Sciences > Biotechnology > Biologics > RNA Vaccines
Translational Research
Life Sciences > Health Sciences > Biomedical Research > Translational Research
Antisense Oligonucleotide Therapy
Life Sciences > Biological Sciences > Biotechnology > Biologics > Antisense Oligonucleotide Therapy